PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
3,5-di(undecan-2-yl)dihydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole | 700-210-9 | 1001161-63-2 | - | - | 2 | - | - | - | - | - | - | Details |
Copolymer of acetonoxime and 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate | 600-028-9 | 1001254-87-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
3-Aminooctan-4-ol | 482-070-6 | 1001354-72-8 | - | - | 1 | - | - | - | - | - | - | Details |
1-Propanone, 2-hydroxy-2-methyl-, 1-(4-C10-13-alkylphenyl) derivs. | 600-033-6 | 1001416-18-7 | - | - | 2 | - | 1 | - | - | - | - | Details |
Cyclohexapentylose | 233-007-4 | 10016-20-3 | - | - | - | - | 1 | - | - | - | - | Details |
1-ethoxy-2-(2-methoxyethoxy)ethane | 213-690-5 | 1002-67-1 | - | - | 3 | - | - | 1 | - | - | - | Details |
Wheat, ext., hydrolyzed | 309-358-5 | 100209-50-5 | - | - | - | - | 1 | - | - | - | - | Details |
Pentyl D-glucoside | 309-363-2 | 100231-63-8 | - | - | - | - | 1 | - | - | - | - | Details |
Morpholine hydrochloride | 233-029-4 | 10024-89-2 | - | - | - | - | 1 | - | - | - | - | Details |
Neodymium trichloride | 233-031-5 | 10024-93-8 | - | - | - | - | 1 | - | - | - | - | Details |
Dinitrogen oxide | 233-032-0 | 10024-97-2 | - | - | 1 | - | - | 1 | - | - | - | Details |
Disulphur dichloride | 233-036-2 | 10025-67-9 | - | - | 2 | - | - | - | - | - | - | Details |
Tin(II) chloride dihydrate | 600-045-1 | 10025-69-1 | - | - | - | - | 1 | - | - | - | - | Details |
Chromium trichloride | 233-038-3 | 10025-73-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
Trichlorosilane | 233-042-5 | 10025-78-2 | - | - | 5 | - | 1 | 1 | - | - | - | Details |
Phosphoryl trichloride | 233-046-7 | 10025-87-3 | - | - | 1 | - | - | - | - | - | - | Details |
Antimony trichloride | 233-047-2 | 10025-91-9 | 1 | - | 1 | - | - | - | - | - | - | Details |
Dipotassium tetrachloroplatinate | 233-050-9 | 10025-99-7 | - | - | 1 | - | - | - | - | - | - | Details |
Silicon tetrachloride | 233-054-0 | 10026-04-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
Zirconium tetrachloride | 233-058-2 | 10026-11-6 | - | - | - | - | 1 | - | - | - | - | Details |
Ozone | 233-069-2 | 10028-15-6 | - | - | - | 1 | - | 1 | - | - | - | Details |
Nickel difluoride | 233-071-3 | 10028-18-9 | - | - | 2 | - | - | - | - | - | - | Details |
diiron tris(sulphate) | 233-072-9 | 10028-22-5 | 1 | - | 2 | - | - | - | - | - | - | Details |
Tetrahydro-2,5-dimethylfuran | 213-707-6 | 1003-38-9 | - | - | - | - | 1 | - | - | - | - | Details |
Tin dibromide | 233-087-0 | 10031-24-0 | - | - | - | - | 1 | - | - | - | - | Details |